A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer
Authors 0
- Author list not loaded yet.
Cited by 2 stored of 46
2 results
2 results